Sandoz

A global leader in generics and biosimilars

At Sandoz, we are proud of our long history on the front line of scientific progress. For more than 130 years, we have been discovering, developing, and delivering medicines that had improved and extended the lives of millions of people around the world.

We are a global leader in generic and biosimilar medicines with a growing portfolio of over 1000 molecules covering all major therapeutic areas.

We are the largest generics company in Europe, the second largest globally, and aspire to be the world’s leading and most-valued generics company.

• 100+ countries
• 50+ oncology products
• 21000+ employees
• 300 million packs of antibiotics
• 500 million patients reached every year

Sandoz B2B: APIs, FDFs, and CDMO

Sandoz B2B is a global business unit providing third-party pharmaceutical companies with access to an extensive portfolio of APIs and finished dosage forms (FDFs).These are manufactured to the highest standards across our global network.

We are also a leading contract development and manufacturing organization (CDMO), providing end-to-end solutions for our partners’ needs. We offer a full range of services from bulk production to final product packaging. Our well-established global network of cGMP-audited sites guarantees quality at each step of the manufacturing process.

Beyond medicine

Our commitment extends beyond our supply of medicines. We are committed to reducing the carbon footprint of our supply chain (carbon neutral by 2025 in our operations, and across our supply chain by 2030).

 
We are Sandoz B2B, and together with our partners, we are committed to pioneering new ways to reach and serve more patients around the world.